Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Biomaterials Science|May 21, 2021
Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeuticsXinxin Liu, Zhongwen Yuan, Zheng Tang, et al.Biomaterials Science|November 29, 2022
Correction: Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeuticsXinxin Liu, Zhongwen Yuan, Zheng Tang, et al.Angewandte Chemie (International Ed. in English)|April 30, 2024
Autophagy-Inducing MoO3-x Nanowires Boost Photothermal-Triggered Cancer ImmunotherapyLizhen He, Qi Chen, Qichen Lu, et al.Pharmaceutics|January 21, 2023
Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRIGuanfu Liu, Jiabao Ling, Lizhen He, et al.ESC Heart Failure|April 14, 2022
Association of lipoprotein (a) and 1 year prognosis in patients with heart failure with reduced ejection fractionZhiming Li, Jingguang Liu, Jian Shen, et al.Biomaterials|November 11, 2023
High rapamycin-loaded hollow mesoporous Prussian blue nanozyme targets lesion area of spinal cord injury to recover locomotor functionKui Shen, Xiaowei Li, Guanning Huang, et al.Postgraduate Medicine|October 9, 2020
Sex-specific cardiac and vascular responses to hypertension in Chinese populations without overt cardiovascular diseasesZhiming Li, Jingguang Liu, Jian Shen, et al.Nanoscale|February 24, 2021
Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophagesXiaoying Li, Xiaoming Guo, Jiabao Ling, et al.Journal of Materials Chemistry. B|April 9, 2020
A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapyLizhen He, Yanyu Huang, Yanzhou Chang, et al.Journal of Materials Chemistry. B|June 23, 2020
Correction: A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapyLizhen He, Yanyu Huang, Yanzhou Chang, et al.Pageof 8